Screener
CorMedix CRMD Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by CorMedix in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The source filing: CorMedix’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 8:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001410098-26-000021
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities | ||
| Accounts payable | $12,827 | $7,884 |
| Accrued expenses and other liabilities | 112,773 | 163,370 |
| Contingent Consideration, short-term | 3,176 | 3,015 |
| Total current liabilities | 128,776 | 174,269 |
| Convertible senior notes, net of deferred financing costs | 144,885 | 144,626 |
| Contingent Consideration, net of current portion | 102,397 | 99,101 |
Item 1. Unaudited Condensed Consolidated Financial Statements.
FAQ
- What is CorMedix's accrued expenses?
- CorMedix (CRMD) reported accrued expenses of $112.77M in Q1 2026.
- How has CorMedix's accrued expenses changed year-over-year?
- CorMedix's accrued expenses increased by 384.5% year-over-year, from $23.27M to $112.77M.
- What is the long-term trend for CorMedix's accrued expenses?
- Over 5 years (2020 to 2025), CorMedix's accrued expenses has grown at a 123.6% compound annual growth rate (CAGR), from $2.92M to $163.37M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about CorMedix's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude